The genetics of autoimmune Addison disease: past, present and future

Nat Rev Endocrinol. 2022 Jul;18(7):399-412. doi: 10.1038/s41574-022-00653-y. Epub 2022 Apr 11.

Abstract

Autoimmune Addison disease is an endocrinopathy that is fatal if not diagnosed and treated in a timely manner. Its rarity has hampered unbiased studies of the predisposing genetic factors. A 2021 genome-wide association study, explaining up to 40% of the genetic susceptibility, has revealed new disease loci and reproduced some of the previously reported associations, while failing to reproduce others. Credible risk loci from both candidate gene and genome-wide studies indicate that, like one of its most common comorbidities, type 1 diabetes mellitus, Addison disease is primarily caused by aberrant T cell behaviour. Here, we review the current understanding of the genetics of autoimmune Addison disease and its position in the wider field of autoimmune disorders. The mechanisms that could underlie the effects on the adrenal cortex are also discussed.

Publication types

  • Review

MeSH terms

  • Addison Disease* / genetics
  • Autoimmune Diseases* / epidemiology
  • Autoimmune Diseases* / genetics
  • Diabetes Mellitus, Type 1* / genetics
  • Endocrine System Diseases*
  • Genetic Predisposition to Disease / genetics
  • Genome-Wide Association Study
  • Humans